| Dr Ryan P Brown, MD | |
|
210 N Tillotson Ave, Muncie, IN 47304-3988 | |
| (765) 747-4498 | |
| Not Available |
| Full Name | Dr Ryan P Brown |
|---|---|
| Gender | Male |
| Speciality | Family Practice |
| Experience | 19 Years |
| Location | 210 N Tillotson Ave, Muncie, Indiana |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1740378215 | NPI | - | NPPES |
| 201019410 | Medicaid | IN | |
| M12240473 | Other | IN | MEDICARE PTAN |
| P01277189 | Other | IN | RAILROAD MEDICARE |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Indiana University Health Ball Memorial Physicians Inc | 9537072640 | 297 |
News Archive
Most cases of autism appear to be associated with the appearance of new mutations that are not inherited from the child's parents, researchers from the University of Washington School of Medicine report.
Medical devices known as IV connectors, through which intravenous medication and nutrition are provided to a patient, can play a crucial role in protecting patients from life-threatening infections and other complications. But some types of connectors are much more prone to dangerous complications, according to a recent poster presentation at an international meeting of oncology nurses, the 17th International Conference on Cancer Nursing, held Sept. 9-13 in Prague, Czech Republic.
Delcath Systems, Inc. announced today that the Company has entered into an initial launch and training agreement with the Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital (NKI-AVL) in Amsterdam, The Netherlands.
Uroplasty, Inc., a medical device company that develops, manufactures and markets innovative proprietary products for the treatment of voiding dysfunctions, today announced that National Government Services has issued a positive coverage decision for Posterior Tibial Nerve Stimulation (PTNS) for the treatment of urinary urgency, urinary frequency and urge incontinence associated with overactive bladder (OAB). Coverage for the proprietary Urgent PC device was effective August 10, 2014.
A report in Cancer Research, a journal of the American Association for Cancer Research, highlights a new biomarker that may be useful in identifying patients with recurrent glioblastoma, or brain tumors, who would respond better to anti-vascular endothelial growth factor therapy, specifically cediranib.
› Verified 6 days ago
| Entity Name | Indiana University Health Ball Memorial Physicians Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1235455544 PECOS PAC ID: 9537072640 Enrollment ID: O20031110000505 |
News Archive
Most cases of autism appear to be associated with the appearance of new mutations that are not inherited from the child's parents, researchers from the University of Washington School of Medicine report.
Medical devices known as IV connectors, through which intravenous medication and nutrition are provided to a patient, can play a crucial role in protecting patients from life-threatening infections and other complications. But some types of connectors are much more prone to dangerous complications, according to a recent poster presentation at an international meeting of oncology nurses, the 17th International Conference on Cancer Nursing, held Sept. 9-13 in Prague, Czech Republic.
Delcath Systems, Inc. announced today that the Company has entered into an initial launch and training agreement with the Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital (NKI-AVL) in Amsterdam, The Netherlands.
Uroplasty, Inc., a medical device company that develops, manufactures and markets innovative proprietary products for the treatment of voiding dysfunctions, today announced that National Government Services has issued a positive coverage decision for Posterior Tibial Nerve Stimulation (PTNS) for the treatment of urinary urgency, urinary frequency and urge incontinence associated with overactive bladder (OAB). Coverage for the proprietary Urgent PC device was effective August 10, 2014.
A report in Cancer Research, a journal of the American Association for Cancer Research, highlights a new biomarker that may be useful in identifying patients with recurrent glioblastoma, or brain tumors, who would respond better to anti-vascular endothelial growth factor therapy, specifically cediranib.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Ryan P Brown, MD 250 N Shadeland Ave, Indianapolis, IN 46219-4959 Ph: () - | Dr Ryan P Brown, MD 210 N Tillotson Ave, Muncie, IN 47304-3988 Ph: (765) 747-4498 |
News Archive
Most cases of autism appear to be associated with the appearance of new mutations that are not inherited from the child's parents, researchers from the University of Washington School of Medicine report.
Medical devices known as IV connectors, through which intravenous medication and nutrition are provided to a patient, can play a crucial role in protecting patients from life-threatening infections and other complications. But some types of connectors are much more prone to dangerous complications, according to a recent poster presentation at an international meeting of oncology nurses, the 17th International Conference on Cancer Nursing, held Sept. 9-13 in Prague, Czech Republic.
Delcath Systems, Inc. announced today that the Company has entered into an initial launch and training agreement with the Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital (NKI-AVL) in Amsterdam, The Netherlands.
Uroplasty, Inc., a medical device company that develops, manufactures and markets innovative proprietary products for the treatment of voiding dysfunctions, today announced that National Government Services has issued a positive coverage decision for Posterior Tibial Nerve Stimulation (PTNS) for the treatment of urinary urgency, urinary frequency and urge incontinence associated with overactive bladder (OAB). Coverage for the proprietary Urgent PC device was effective August 10, 2014.
A report in Cancer Research, a journal of the American Association for Cancer Research, highlights a new biomarker that may be useful in identifying patients with recurrent glioblastoma, or brain tumors, who would respond better to anti-vascular endothelial growth factor therapy, specifically cediranib.
› Verified 6 days ago
Shereene Grant, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 333 S Madison St, Muncie, IN 47305 Phone: 765-286-7000 Fax: 765-213-2769 | |
Mohammad S Bahrami, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 3631 N Morrison Rd, Muncie, IN 47304 Phone: 765-281-3443 Fax: 765-286-4124 | |
Dr. Jeffrey C Bird, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 221 N Celia Ave, Muncie, IN 47303 Phone: 765-741-2999 Fax: 765-747-3175 | |
Dr. Jeremy J. Hunt, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 3600 W Bethel Ave, Muncie, IN 47304 Phone: 765-284-7738 Fax: 765-213-3713 | |
Gregory K Gahl, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 3631 N Morrison Rd, Muncie, IN 47304 Phone: 765-281-3443 Fax: 765-286-4124 | |
Lisa Renee Clay, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 210 N Celia Ave, Muncie, IN 47303 Phone: 765-702-4633 | |
Dr. Ann Lorae Morris, M.D. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 3025 N Oakwood Ave, Muncie, IN 47304 Phone: 765-286-0862 |